{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-24-007571","form_type":"8-K","ticker":null,"cik":"0001617765","company_name":"EVOME MEDICAL TECHNOLOGIES INC.","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.268712+00:00","generated_at":"2026-06-04T04:41:32.459624+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Evome Medical posts FY2023 preliminary revenue C$62.6M, positive Adj EBITDA C$852K","bullets":["Revenue C$62.6M, gross margin C$22.5M (36% of sales); Adjusted EBITDA positive C$852K.","CEO Seckler states turnaround completed after H1 losses; two consecutive quarters of positive Adj EBITDA.","Full FY2023 financial statements (10-K) to be filed April 16, 2024.","Plans to reduce debt by divesting non-core units; launched RST product; SpaceTek Knee expected late 2024.","Fourth-quarter strength drove full-year positive EBITDA; first quarter 2024 improvements continuing."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-24-007571","json":"https://secwatch.observer/filing/0001062993-24-007571.json","markdown":"https://secwatch.observer/filing/0001062993-24-007571.md","text":"https://secwatch.observer/filing/0001062993-24-007571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324007571/0001062993-24-007571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324007571/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:41:32.459624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90ccc2673d3081801e081c3460a3c5f12b7ad16e","claim":"EVOME MEDICAL TECHNOLOGIES INC. reported preliminary financial results for the year ended December 31, 2023.","evidence_excerpt":"On April 1, 2024, Evome Medical Technologies Inc. issued a press release containing certain preliminary annual financial results for the year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324007571/0001062993-24-007571-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}